Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID DTD0251 Transporter Info
Gene Name SLC2A1
Transporter Name Glucose transporter type 1, erythrocyte/brain
Gene ID
6513
UniProt ID
P11166

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 5 TF(s) Regulating This DT

        ATF2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Cyclic AMP-dependent transcription factor ATF-2 Transcription Factor Info

Tissue

 Embryo

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        BACH2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Transcription regulator protein BACH2 Transcription Factor Info

Tissue

 Blood

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription regulator protein BACH2 (BACH2) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        FOSL1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Fos-related antigen 1 Transcription Factor Info

Tissue

 Bone marrow; Breast; Colon

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Fos-related antigen 1 (FOSL1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        FOSL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Fos-related antigen 2 Transcription Factor Info

Tissue

 Brain; Breast; Liver; Lung

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Fos-related antigen 2 (FOSL2) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        NFE2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Transcription factor NF-E2 45 kDa subunit Transcription Factor Info

Tissue

 Blood; Bone marrow; Liver

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor NF-E2 45 kDa subunit (NFE2) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

      Class 1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 13 TF(s) Regulating This DT

        AHR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC2A1 gene in teratocarcinoma condition [4]

TF Protein Name

 Aryl hydrocarbon receptor Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Teratocarcinoma [ICD11: 2C12.0Y]

Tissue

 Embryo

Related DT Changes

 Down regulating

Experimental Material

 Mouse teratocarcinoma cells (P19)

Detailed Description

 Aryl hydrocarbon receptor (AHR) has been reported to repress the transcription of SLC2A1 gene in teratocarcinoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

        ASCL1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Achaete-scute homolog 1 Transcription Factor Info

Tissue

 Embryo; Lung

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        EPAS1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC2A1 gene in health condition [5]

TF Protein Name

 Endothelial PAS domain-containing protein 1 Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Embryo

Related DT Changes

 Down regulating

Experimental Material

 Mouse white adipose tissue preadipocytes cells (3T3-L1)

Detailed Description

 Endothelial PAS domain-containing protein 1 (EPAS1) has been reported to repress the transcription of SLC2A1 gene in health condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

        HIF1A 

Click to Show/Hide to Show 10 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in ataxia Telangiectasia condition [6]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Ataxia telangiectasia [ICD11: 4A01.31]

Tissue

 Blood

Related DT Changes

 Up regulating

Experimental Material

 Human ataxia telangiectasia syndrome cells (GM03332)

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in ataxia Telangiectasia condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 2

 Activation of SLC2A1 gene in gestational choriocarcinoma condition [7]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Gestational choriocarcinoma [ICD11: 2C75]

Tissue

 Trophoderm

Related DT Changes

 Up regulating

Experimental Material

 Human gestational choriocarcinoma cells (BeWo)

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in gestational choriocarcinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 3

 Activation of SLC2A1 gene in health condition [8]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Knee

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6 mice

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 4

 Activation of SLC2A1 gene in pregnancy condition [9]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Pregnancy [ICD11: JA00-JA2Z]

Tissue

 Breast

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6 mice

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in pregnancy condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 5

 Activation of SLC2A1 gene in breast cancer condition [10]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

 Breast cancer [ICD11: 2C60-2C6Z]

Tissue

 Breast

Related DT Changes

 Up regulating

Experimental Material

 Human invasive breast carcinoma of no special type cells (MCF-7)

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in breast cancer condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 6

 Activation of SLC2A1 gene in ovarian cancer condition [11]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

 Ovarian cancer [ICD11: 2C73]

Tissue

 Ovary

Related DT Changes

 Up regulating

Experimental Material

 human ovarian adenocarcinoma cell isolates

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in ovarian cancer condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 7

 Activation of SLC2A1 gene in prostate cancer condition [12]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

 Prostate cancer [ICD11: 2C82]

Tissue

 Prostate

Related DT Changes

 Up regulating

Experimental Material

 Human prostate carcinoma cells (LNCaP)

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 8

 Activation of SLC2A1 gene in sARS-CoV-2 infection condition [13]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

 SARS-CoV-2 infection [ICD11: 1D92]

Tissue

 Lung

Related DT Changes

 Up regulating

Experimental Material

 Syrian hamsters

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A1 gene in sARS-CoV-2 infection condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 9

 Activation of SLC2A1 gene in hepatoblastoma condition [14]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

 Hepatoblastoma [ICD11: 2C12.01]

Tissue

 Liver

Related DT Changes

 up regulating

Experimental Material

 Human hepatoblastoma cells (HepG2)

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A), influenced by the exogenous ibuprofen, has been reported to activate the transcription of SLC2A1 gene in hepatoblastoma condition , which leads to an increased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 10

 Activation of SLC2A1 gene in hepatocellular carcinoma condition [15]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

 Hepatocellular carcinoma [ICD11: 2C12.02]

Tissue

 Liver

Related DT Changes

 up regulating

Experimental Material

 Human childhood hepatocellular carcinoma cells (Hep3B)

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A), influenced by the exogenous ibuprofen, has been reported to activate the transcription of SLC2A1 gene in hepatocellular carcinoma condition , which leads to an increased expression of the drug transporter Glucose transporter type 1.

        MXI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Max-interacting protein 1 Transcription Factor Info

Tissue

 Blood; Bone marrow; Brain; Cervix; Embryo; Liver; Lung

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Max-interacting protein 1 (MXI1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        MYC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in liver cancer condition [17]

TF Protein Name

 Myc proto-oncogene protein Transcription Factor Info

Studied Phenotype

 Liver cancer [ICD11: 2C12]

Tissue

 Liver

Related DT Changes

 Up regulating

Experimental Material

 BALB/c mice

Detailed Description

 Myc proto-oncogene protein (MYC) has been reported to activate the transcription of SLC2A1 gene in liver cancer condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

        MYOD1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC2A1 gene in health condition [18]

TF Protein Name

 Myoblast determination protein 1 Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Skeletal muscle

Related DT Changes

 Down regulating

Experimental Material

 Rat skeletal muscle myoblast cells (L6E9)

Detailed Description

 Myoblast determination protein 1 (MYOD1) has been reported to repress the transcription of SLC2A1 gene in health condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

        SREBF2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in glioma condition [19]

TF Protein Name

 Sterol regulatory element-binding protein 2 Transcription Factor Info

Studied Phenotype

 Glioma [ICD11: 2A00.0]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 human glioma cell isolates

Detailed Description

 Sterol regulatory element-binding protein 2 (SREBF2) has been reported to activate the transcription of SLC2A1 gene in glioma condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

        TCF12 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Transcription factor 12 Transcription Factor Info

Tissue

 Blood; Brain; Lung; Uterus

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor 12 (TCF12) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        TCF3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Transcription factor E2-alpha Transcription Factor Info

Tissue

 Blood; Bone marrow

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor E2-alpha (TCF3) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        TFAP4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Transcription factor AP-4 Transcription Factor Info

Tissue

 Blood

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor AP-4 (TFAP4) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        TWIST1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in health condition [20]

TF Protein Name

 Twist-related protein 1 Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Kidney

Related DT Changes

 Up regulating

Experimental Material

 Human kidney human embryonic kidney 293T cells (HEK 293T)

Detailed Description

 Twist-related protein 1 (TWIST1) has been reported to activate the transcription of SLC2A1 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

        USF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Upstream stimulatory factor 1 Transcription Factor Info

Tissue

 Bone marrow; Brain; Embryo; Liver; Uterus

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Upstream stimulatory factor 1 (USF1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

      Class 1.3: Basic helix-span-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        TFAP2C 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Transcription factor AP-2 gamma Transcription Factor Info

Tissue

 Breast; Cervix; Skin

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 5 TF(s) Regulating This DT

        HNF4G 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Hepatocyte nuclear factor 4-gamma Transcription Factor Info

Tissue

 Liver

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Hepatocyte nuclear factor 4-gamma (HNF4G) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        NR3C1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in pregnancy condition [21]

TF Protein Name

 Glucocorticoid receptor Transcription Factor Info

Studied Phenotype

 Pregnancy [ICD11: JA00-JA2Z]

Tissue

 Trophoderm

Related DT Changes

 Up regulating

Experimental Material

 human mononucleated trophoblast cell isolates

Detailed Description

 Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC2A1 gene in pregnancy condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

        PGR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in pregnancy condition [22]

TF Protein Name

 Progesterone receptor Transcription Factor Info

Studied Phenotype

 Pregnancy [ICD11: JA00-JA2Z]

Tissue

 Endometrium

Related DT Changes

 Up regulating

Experimental Material

 Suffolk sheep

Detailed Description

 Progesterone receptor (PGR) has been reported to activate the transcription of SLC2A1 gene in pregnancy condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

        PPARD 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC2A1 gene in health condition [23]

TF Protein Name

 Peroxisome proliferator-activated receptor delta Transcription Factor Info

Affected Drug/Substrate

 Hexose

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Aorta

Related DT Changes

 Down regulating

Experimental Material

 Bovine aortic endothelial cells

Detailed Description

 Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SLC2A1 gene in health condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

        PPARG 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in health condition [24]

TF Protein Name

 Peroxisome proliferator-activated receptor gamma Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Embryo

Related DT Changes

 up regulating

Experimental Material

 Mouse differentiated adipocytes (3T3-L1)

Detailed Description

 Peroxisome proliferator-activated receptor gamma (PPARG), influenced by the exogenous rosiglitazone, has been reported to activate the transcription of SLC2A1 gene in health condition , which leads to an increased expression of the drug transporter Glucose transporter type 1.

      Class 2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 12 TF(s) Regulating This DT

        KLF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Krueppel-like factor 1 Transcription Factor Info

Tissue

 Blood

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Krueppel-like factor 1 (KLF1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        KLF3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Krueppel-like factor 3 Transcription Factor Info

Tissue

 Colon

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Krueppel-like factor 3 (KLF3) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        KLF5 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Krueppel-like factor 5 Transcription Factor Info

Tissue

 Colon; Pancreatic ductal; Stomach

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Krueppel-like factor 5 (KLF5) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        KLF9 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Krueppel-like factor 9 Transcription Factor Info

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Krueppel-like factor 9 (KLF9) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Myc-associated zinc finger protein Transcription Factor Info

Tissue

 Blood; Bone marrow; Cervix; Liver; Lung

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        MECOM 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Histone-lysine N-methyltransferase MECOM Transcription Factor Info

Tissue

 Colon

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Histone-lysine N-methyltransferase MECOM (MECOM) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        SP1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC2A1 gene in health condition [18]

TF Protein Name

 Transcription factor Sp1 Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Skeletal muscle

Related DT Changes

 Up regulating

Experimental Material

 Rat skeletal muscle myoblast cells (L6E9)

Detailed Description

 Transcription factor Sp1 (SP1) has been reported to activate the transcription of SLC2A1 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 1.

        SP4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Transcription factor Sp4 Transcription Factor Info

Tissue

 Embryo

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor Sp4 (SP4) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        ZBTB7A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Zinc finger and BTB domain-containing protein 7A Transcription Factor Info

Tissue

 Bone marrow; Liver; Uterus

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        ZFX 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Zinc finger X-chromosomal protein Transcription Factor Info

Tissue

 Brain

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Zinc finger X-chromosomal protein (ZFX) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        ZNF263 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Zinc finger protein 263 Transcription Factor Info

Tissue

 Bone marrow; Kidney

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Zinc finger protein 263 (ZNF263) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        ZNF92 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Zinc finger protein 92 Transcription Factor Info

Tissue

 Retina

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Zinc finger protein 92 (ZNF92) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 3 TF(s) Regulating This DT

        LHX2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 LIM/homeobox protein Lhx2 Transcription Factor Info

Tissue

 Epithelium

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 LIM/homeobox protein Lhx2 (LHX2) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        PBX1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Pre-B-cell leukemia transcription factor 1 Transcription Factor Info

Tissue

 Bone marrow

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Pre-B-cell leukemia transcription factor 1 (PBX1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        PBX3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Pre-B-cell leukemia transcription factor 3 Transcription Factor Info

Tissue

 Blood; Brain; Lung

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Pre-B-cell leukemia transcription factor 3 (PBX3) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

      Class 3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        E2F7 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Transcription factor E2F7 Transcription Factor Info

Tissue

 Colon

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor E2F7 (E2F7) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

      Class 3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 6 TF(s) Regulating This DT

        EHF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 ETS homologous factor Transcription Factor Info

Tissue

 Bronchus

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 ETS homologous factor (EHF) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        ETV1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 ETS translocation variant 1 Transcription Factor Info

Tissue

 Prostate

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 ETS translocation variant 1 (ETV1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        GABPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 GA-binding protein alpha chain Transcription Factor Info

Tissue

 Blood; Bone marrow; Liver; Prostate

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 GA-binding protein alpha chain (GABPA) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        IRF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Interferon regulatory factor 1 Transcription Factor Info

Tissue

 Bone marrow; Pancreatic ductal

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Interferon regulatory factor 1 (IRF1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        IRF4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Interferon regulatory factor 4 Transcription Factor Info

Tissue

 Blood

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Interferon regulatory factor 4 (IRF4) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

        MYB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 Transcriptional activator Myb Transcription Factor Info

Tissue

 Blood

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcriptional activator Myb (MYB) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

TF Superclass 5: alpha-Helices exposed by beta-structures

      Class 5.1: MADS box factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        SRF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Serum response factor Transcription Factor Info

Tissue

 Embryo; Uterus

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Serum response factor (SRF) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

TF Superclass 6: Immunoglobulin fold

      Class 6.1: Rel homology region factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        EBF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [16]

TF Protein Name

 Transcription factor COE1 Transcription Factor Info

Tissue

 Blood

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription factor COE1 (EBF1) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

      Class 6.3: p53 domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        TP53 

Click to Show/Hide to Show 3 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC2A1 gene in osteosarcoma condition [25]

TF Protein Name

 Cellular tumor antigen p53 Transcription Factor Info

Affected Drug/Substrate

 Glucose

Studied Phenotype

 Osteosarcoma [ICD11: 2B51]

Tissue

 Bone

Related DT Changes

 Down regulating

Experimental Material

 Human osteosarcoma cells (Saos-2)

Detailed Description

 Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC2A1 gene in osteosarcoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 2

 Repression of SLC2A1 gene in colon cancer condition [26]

TF Protein Name

 Cellular tumor antigen p53 Transcription Factor Info

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Tissue

 Colon

Related DT Changes

 Down regulating

Experimental Material

 Human colon carcinoma cells (HCT-116)

Detailed Description

 Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC2A1 gene in colon cancer condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

       Transcriptional Phenomenon 3

 Repression of SLC2A1 gene in wilms tumor condition [27]

TF Protein Name

 Cellular tumor antigen p53 Transcription Factor Info

Studied Phenotype

 Wilms tumor [ICD11: 2C90.Y]

Tissue

 Kidney

Related DT Changes

 Down regulating

Experimental Material

 human Wilms tumor cell isolates

Detailed Description

 Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC2A1 gene in wilms tumor condition, which leads to a decreased expression of the drug transporter Glucose transporter type 1.

      Class 6.7: Grainyhead domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GRHL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Grainyhead-like protein 2 homolog Transcription Factor Info

Tissue

 Breast; Bronchus; Ovary; Prostate

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

TF Superclass 7: beta-Hairpin exposed by an alpha/beta-scaffold

      Class 7.1: SMAD/NF-1 DNA-binding domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NFIC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [1]

TF Protein Name

 Nuclear factor 1 C-type Transcription Factor Info

Tissue

 Brain; Uterus

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Nuclear factor 1 C-type (NFIC) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

TF Superclass 10: Yet undefined DNA-binding domains

      Class 10.1: Other factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GTF2B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [2]

TF Protein Name

 Transcription initiation factor IIB Transcription Factor Info

Tissue

 Cervix; Lung

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Transcription initiation factor IIB (GTF2B) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.

      Class 10.5: GTF2I domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GTF2I 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC2A1 gene [3]

TF Protein Name

 General transcription factor II-I Transcription Factor Info

Tissue

 Foreskin

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 General transcription factor II-I (GTF2I) can directly bind to the SLC2A1 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 1.
References
1 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
2 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
3 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
4 Dioxin affects glucose transport via the arylhydrocarbon receptor signal cascade in pluripotent embryonic carcinoma cells. Endocrinology. 2007 Dec;148(12):5902-12.
5 EPAS1 promotes adipose differentiation in 3T3-L1 cells. J Biol Chem. 2004 Sep 24;279(39):40946-53.
6 Loss of ATM positively regulates the expression of hypoxia inducible factor 1 (HIF-1) through oxidative stress: Role in the physiopathology of the disease. Cell Cycle. 2010 Jul 15;9(14):2814-22.
7 Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells. J Endocrinol. 2004 Oct;183(1):145-54.
8 Hypoxia regulation of facilitated glucose transporter-1 and glucose transporter-3 in mouse chondrocytes mediated by HIF-1alpha. Joint Bone Spine. 2008 Mar;75(2):176-81.
9 Differential regulation of GLUT1 and GLUT8 expression by hypoxia in mammary epithelial cells. Am J Physiol Regul Integr Comp Physiol. 2014 Aug 1;307(3):R237-47.
10 Expression and hypoxia-responsiveness of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 in mammary gland malignant cell lines. Acta Biochim Pol. 2005;52(4):881-8.
11 Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncol Rep. 2008 Jan;19(1):111-6.
12 Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol Cancer Res. 2007 Apr;5(4):383-91.
13 HIF-1alpha-Dependent Metabolic Reprogramming, Oxidative Stress, and Bioenergetic Dysfunction in SARS-CoV-2-Infected Hamsters. Int J Mol Sci. 2022 Dec 29;24(1):558.
14 Aluminum toxicity triggers the nuclear translocation of HIF-1alpha and promotes anaerobiosis in hepatocytes. Toxicol In Vitro. 2007 Feb;21(1):16-24.
15 Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood. 2005 Jun 15;105(12):4613-9.
16 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-232. (ID:ENSG00000117394)
17 Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 2000 Jul 21;275(29):21797-800.
18 Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J Biol Chem. 1997 May 16;272(20):12913-21.
19 SREBP2/Rab11s/GLUT1/6 network regulates proliferation and migration of glioblastoma. Pathol Res Pract. 2022 Dec;240:154176.
20 Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro. In Vitro Cell Dev Biol Anim. 2021 Dec;57(10):933-943.
21 Placental glucose transporter expression is regulated by glucocorticoids. J Clin Endocrinol Metab. 1999 Apr;84(4):1445-52.
22 Select nutrients in the ovine uterine lumen. ii. glucose transporters in the uterus and peri-implantation conceptuses. Biol Reprod. 2009 Jan;80(1):94-104.
23 The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta. Diabetes. 2010 Apr;59(4):808-18.
24 Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol. 2001 Oct;15(10):1729-38.; 2001 Oct;15(10):1729-38.
25 The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004 Apr 1;64(7):2627-33.
26 Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer. J Biol Chem. 2011 Dec 2;286(48):41600-41615.
27 Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors. Pediatr Dev Pathol. 2012 Jul-Aug;15(4):286-92.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.